# Safety Study of Dabigatran in CADASIL

> **NCT01361763** · PHASE2 · UNKNOWN · sponsor: **S. Andrea Hospital** · enrollment: 50 (estimated)

## Conditions studied

- CADASIL

## Interventions

- **DRUG:** Dabigatran
- **DRUG:** Antiplatelets

## Key facts

- **NCT ID:** NCT01361763
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2014-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361763, "Safety Study of Dabigatran in CADASIL". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01361763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*